Kank-A

Manufacturer: Blistex Inc.
Effective date: 2024-12-17
Label type: HUMAN OTC DRUG LABEL
Version: 5
Source: full-release
Hydrated at: 2026-06-01 00:45:06

Label at a glance#

ProductKank-A Mouth Pain

Active ingredientBenzocaine

Label structure9 sections

Indications and uses

for the temporary relief of pain due to canker sores, minor irritation of the mouth and gums caused by dentures or orthodontic appliances, or minor injury of the mouth or gums

Dosage and administration

adults and children 2 years of age and older: to assure formation of a long-lasting film coating, dry affected area and apply medication undiluted with applicator allow a few seconds for coating to form use up to 4 times daily, or as directed by a dentist or doctor children under 12 years of age should be supervised in the use of this product children under 2 years of age: do not use

Storage and handling

do not purchase if package has been opened cap tightly after use to avoid evaporation avoid contact with the eyes avoid contact with clothing and household/furniture surfaces to prevent possible staining this is a personal care item, and should be used by one individual only

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Benzocaine 20.0% (w/w)

Purpose

OTC - PURPOSE SECTION

Oral anesthetic/analgesic

Uses

INDICATIONS & USAGE SECTION

for the temporary relief of pain due to canker sores, minor irritation of the mouth and gums caused by dentures or orthodontic appliances, or minor injury of the mouth or gums

Warnings

WARNINGS SECTION

METHEMOGLOBINEMIA WARNING

SPL UNCLASSIFIED SECTION

Use of this product may cause methemoglobinemia, a serious condition that must be treated promptly because it reduces the amount of oxygen carried in blood. This can occur even if you have used this product before. Stop use and seek immediate medical attention if you or a child in your care develops:

pale, gray, or blue colored skin (cyanosis)
headache
rapid heart rate
shortness of breath
dizziness or lightheadedness
fatigue or lack of energy

Allergy alert

OTC - DO NOT USE SECTION

do not use this product if you have a history of allergy to local anesthetics such as procaine, butacaine, benzocaine, or other "caine" anesthetics.

Do not use

OTC - DO NOT USE SECTION

for teething
in children under 2 years of age

When using this product

OTC - WHEN USING SECTION

do not use this product for more than 7 days unless directed by a dentist or doctor. If sore mouth symptoms do not improve in 7 days; if irritation, pain, or redness persists or worsens; or if swelling, rash or fever develops, see your dentist or doctor promptly.
do not exceed recommended dosage.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If more than used for pain is accidentally swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

adults and children 2 years of age and older:
- to assure formation of a long-lasting film coating, dry affected area and apply medication undiluted with applicator
- allow a few seconds for coating to form
- use up to 4 times daily, or as directed by a dentist or doctor
- children under 12 years of age should be supervised in the use of this product
- children under 2 years of age: do not use

Other information

STORAGE AND HANDLING SECTION

do not purchase if package has been opened
cap tightly after use to avoid evaporation
avoid contact with the eyes
avoid contact with clothing and household/furniture surfaces to prevent possible staining
this is a personal care item, and should be used by one individual only

Inactive ingredients

INACTIVE INGREDIENT SECTION

benzyl alcohol, cetylpyridinium chloride, compound benzoin tincture, dimethyl isosorbide, ethylcellulose, flavor, octylacrylamide/acrylates/butylaminoethyl methacrylate copolymer, oleth-10, polyethylene glycol, propylene glycol, ricinus communis (castor) seed oil, SD alcohol 38-B (29.6% v/v), sodium saccharin, sucralose, tannic acid

PRINCIPAL DISPLAY PANEL - 9.75 mL Bottle Package

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

MAXIMUM STRENGTH
KANK-A^®
MOUTH PAIN LIQUID
ORAL ANESTHETIC

Maximum Pain Relief

Forms Protective Coating

For Sores Inside the Mouth

Canker Sores
Denture Abrasions
Brace Irritation

ADA
Accepted
American
Dental
Association ®

CONVENIENT
CONTROL-TIP
APPLICATOR

Net 0.33 fl. oz. (9.75 mL)

Principal Display Panel - 9.75 mL Bottle Package

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
308657	benzocaine 20 % Mucous Membrane Topical Solution	PSN	5
308657	benzocaine 200 MG/ML Mucous Membrane Topical Solution	SCD	5
308657	benzocaine 20 % Mucous Membrane Topical Solution	SY	5

DailyMed Pharmacologic Classes#

Class, Version, Type table
Class	Version	Type	Effective
BENZOCAINE Pharmacologic Class Indexing	2	Indexing - Pharmacologic Class	20180813

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
10157-9477-1	Kank-A Mouth Pain	9.75 mL in 1 BOTTLE, WITH APPLICATOR	LIQUID	9.75		5

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
10157-9477	KANK-A MOUTH PAIN (BENZOCAINE) LIQUID [BLISTEX INC.]	5	Current NDC, Legacy NDC, 1 package rows	20241220_eebc03ba-f849-4e70-a653-834f383b6aa4.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
Benzocaine	ACTIVE INGREDIENT	U3RSY48JW5	1
Benzocaine	ACTIVE MOIETY	U3RSY48JW5	1
BENZYL ALCOHOL	INACTIVE INGREDIENT	LKG8494WBH	1
CASTOR OIL	INACTIVE INGREDIENT	D5340Y2I9G	1
CETYLPYRIDINIUM CHLORIDE	INACTIVE INGREDIENT	D9OM4SK49P	1
DIMETHYL ISOSORBIDE	INACTIVE INGREDIENT	SA6A6V432S	1
ETHYLCELLULOSES	INACTIVE INGREDIENT	7Z8S9VYZ4B	1
OLETH-10	INACTIVE INGREDIENT	JD797EF70J	1
POLYETHYLENE GLYCOL 300	INACTIVE INGREDIENT	5655G9Y8AQ	1
PROPYLENE GLYCOL	INACTIVE INGREDIENT	6DC9Q167V3	1
SACCHARIN SODIUM	INACTIVE INGREDIENT	SB8ZUX40TY	1
SUCRALOSE	INACTIVE INGREDIENT	96K6UQ3ZD4	1
TANNIC ACID	INACTIVE INGREDIENT	28F9E0DJY6	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 17 matching rows.

Kank-A Mouth Pain
Benzocaine
BENZYL ALCOHOL
CETYLPYRIDINIUM CHLORIDE
compound benzoin tincture
DIMETHYL ISOSORBIDE
ETHYLCELLULOSE, UNSPECIFIED
ACRYLATE/BUTYLAMINOETHYL METHACRYLATE/METHYL ACRYLATE/METHYL METHACRYLATE/OCTYLACRYLAMIDE COPOLYMER (40000 WAMW)
OLETH-10
POLYETHYLENE GLYCOL, UNSPECIFIED
POLYETHYLENE GLYCOL 300
PROPYLENE GLYCOL
CASTOR OIL
ALCOHOL
SACCHARIN SODIUM
SUCRALOSE
TANNIC ACID

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
10157-9477	10157-9477-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 16 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
Benzocaine	U3RSY48JW5	ACTIB
BENZYL ALCOHOL	LKG8494WBH	IACT
CETYLPYRIDINIUM CHLORIDE	D9OM4SK49P	IACT
compound benzoin tincture	UJZ8IA4D1U	IACT
DIMETHYL ISOSORBIDE	SA6A6V432S	IACT
ETHYLCELLULOSE, UNSPECIFIED	7Z8S9VYZ4B	IACT
ACRYLATE/BUTYLAMINOETHYL METHACRYLATE/METHYL ACRYLATE/METHYL METHACRYLATE/OCTYLACRYLAMIDE COPOLYMER (40000 WAMW)	8RZ43KFB5K	IACT
OLETH-10	JD797EF70J	IACT
POLYETHYLENE GLYCOL, UNSPECIFIED	3WJQ0SDW1A	IACT
POLYETHYLENE GLYCOL 300	5655G9Y8AQ	IACT
PROPYLENE GLYCOL	6DC9Q167V3	IACT
CASTOR OIL	D5340Y2I9G	IACT
ALCOHOL	3K9958V90M	IACT
SACCHARIN SODIUM	SB8ZUX40TY	IACT
SUCRALOSE	96K6UQ3ZD4	IACT
TANNIC ACID	28F9E0DJY6	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 2 · 96 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
CETYLPYRIDINIUM CHLORIDE	CETYLPYRIDINIUM CHLORIDE	D9OM4SK49P	AEROSOL, METERED / RESPIRATORY (INHALATION)	NA		Exact identifier — unii candidate 10 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	FILM / BUCCAL	1.48 mg		Exact identifier — unii+route 8 equally ranked IID candidates
ETHYLCELLULOSES	ETHYLCELLULOSE	7Z8S9VYZ4B	TABLET, COATED / ORAL	20 mg		Exact identifier — unii candidate 28 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	LIQUID / RESPIRATORY (INHALATION)	10 %w/w		Exact identifier — unii+dosage form 8 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	FILM / BUCCAL	1.48 mg		Exact identifier — unii+route 8 equally ranked IID candidates
ETHYLCELLULOSES	ETHYLCELLULOSE	7Z8S9VYZ4B	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL		1000 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
ETHYLCELLULOSES	ETHYLCELLULOSE	7Z8S9VYZ4B	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	52.5 mg		Exact identifier — unii candidate 28 equally ranked IID candidates
ETHYLCELLULOSES	ETHYLCELLULOSE	7Z8S9VYZ4B	TABLET, EXTENDED RELEASE / ORAL		1120 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
ETHYLCELLULOSES	ETHYLCELLULOSE	7Z8S9VYZ4B	SYSTEM / TOPICAL		10 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
CASTOR OIL	CASTOR OIL	D5340Y2I9G	TABLET, EXTENDED RELEASE / ORAL	23.27 mg		Exact identifier — unii candidate 32 equally ranked IID candidates
SACCHARIN SODIUM	SACCHARIN SODIUM	SB8ZUX40TY	FILM / BUCCAL		3 mg	Exact identifier — unii+route 8 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	LIQUID / RESPIRATORY (INHALATION)	10 %w/w		Exact identifier — unii+dosage form 8 equally ranked IID candidates
CASTOR OIL	CASTOR OIL	D5340Y2I9G	CAPSULE, EXTENDED RELEASE / ORAL		47 mg	Exact identifier — unii candidate 32 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	FILM, SOLUBLE / BUCCAL		5 mg	Exact identifier — unii+route 8 equally ranked IID candidates
CASTOR OIL	CASTOR OIL	D5340Y2I9G	SOLUTION / TOPICAL	1.38 %w/w		Exact identifier — unii candidate 32 equally ranked IID candidates
SUCRALOSE	SUCRALOSE	96K6UQ3ZD4	GUM, CHEWING / BUCCAL		70 mg	Exact identifier — unii+route 2 equally ranked IID candidates
CASTOR OIL	CASTOR OIL	D5340Y2I9G	TABLET / ORAL		17 mg	Exact identifier — unii candidate 32 equally ranked IID candidates
ETHYLCELLULOSES	ETHYLCELLULOSE	7Z8S9VYZ4B	TABLET, DELAYED RELEASE / ORAL	53.8 mg		Exact identifier — unii candidate 28 equally ranked IID candidates
ETHYLCELLULOSES	ETHYLCELLULOSE	7Z8S9VYZ4B	POWDER, FOR SUSPENSION / ORAL	NA		Exact identifier — unii candidate 28 equally ranked IID candidates
ETHYLCELLULOSES	ETHYLCELLULOSE	7Z8S9VYZ4B	CAPSULE, EXTENDED RELEASE / ORAL		153 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
CASTOR OIL	CASTOR OIL	D5340Y2I9G	CAPSULE / ORAL	1.04 mg		Exact identifier — unii candidate 32 equally ranked IID candidates
CASTOR OIL	CASTOR OIL	D5340Y2I9G	CAPSULE, EXTENDED RELEASE / ORAL		47 mg	Exact identifier — unii candidate 32 equally ranked IID candidates
CASTOR OIL	CASTOR OIL	D5340Y2I9G	EMULSION / OPHTHALMIC		32 mg	Exact identifier — unii candidate 32 equally ranked IID candidates
CASTOR OIL	CASTOR OIL	D5340Y2I9G	TABLET, COATED / ORAL	0.9 mg		Exact identifier — unii candidate 32 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	FILM, SOLUBLE / BUCCAL		5 mg	Exact identifier — unii+route 8 equally ranked IID candidates
CETYLPYRIDINIUM CHLORIDE	CETYLPYRIDINIUM CHLORIDE	D9OM4SK49P	CAPSULE / ORAL		2 mg	Exact identifier — unii candidate 10 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	LIQUID / INTRAVENOUS	1.04 %w/v		Exact identifier — unii+dosage form 2 equally ranked IID candidates
CASTOR OIL	CASTOR OIL	D5340Y2I9G	CAPSULE / ORAL	1.04 mg		Exact identifier — unii candidate 32 equally ranked IID candidates
CASTOR OIL	CASTOR OIL	D5340Y2I9G	TABLET, FILM COATED / ORAL	15.29 mg		Exact identifier — unii candidate 32 equally ranked IID candidates
CASTOR OIL	CASTOR OIL	D5340Y2I9G	SPRAY / NASAL	NA		Exact identifier — unii candidate 32 equally ranked IID candidates
CETYLPYRIDINIUM CHLORIDE	CETYLPYRIDINIUM CHLORIDE	D9OM4SK49P	CAPSULE, EXTENDED RELEASE / ORAL	0.02 mg		Exact identifier — unii candidate 10 equally ranked IID candidates
ETHYLCELLULOSES	ETHYLCELLULOSE	7Z8S9VYZ4B	TABLET, FILM COATED, EXTENDED RELEASE / ORAL	52.5 mg		Exact identifier — unii candidate 28 equally ranked IID candidates
ETHYLCELLULOSES	ETHYLCELLULOSE	7Z8S9VYZ4B	TABLET, FILM COATED / ORAL	83 mg		Exact identifier — unii candidate 28 equally ranked IID candidates
ETHYLCELLULOSES	ETHYLCELLULOSE	7Z8S9VYZ4B	POWDER, FOR SUSPENSION / ORAL	NA		Exact identifier — unii candidate 28 equally ranked IID candidates
ETHYLCELLULOSES	ETHYLCELLULOSE	7Z8S9VYZ4B	GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL		1000 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
DIMETHYL ISOSORBIDE	DIMETHYL ISOSORBIDE	SA6A6V432S	CREAM / TOPICAL	15 %w/w		Exact identifier — unii candidate 4 equally ranked IID candidates
ETHYLCELLULOSES	ETHYLCELLULOSE	7Z8S9VYZ4B	TABLET / ORAL		300 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
CASTOR OIL	CASTOR OIL	D5340Y2I9G	OINTMENT / TOPICAL	14.9 %w/w		Exact identifier — unii candidate 32 equally ranked IID candidates
CETYLPYRIDINIUM CHLORIDE	CETYLPYRIDINIUM CHLORIDE	D9OM4SK49P	SOLUTION / OPHTHALMIC	0.01 %w/w		Exact identifier — unii candidate 10 equally ranked IID candidates
ETHYLCELLULOSES	ETHYLCELLULOSE	7Z8S9VYZ4B	TABLET, DELAYED RELEASE / ORAL	53.8 mg		Exact identifier — unii candidate 28 equally ranked IID candidates
CASTOR OIL	CASTOR OIL	D5340Y2I9G	OINTMENT / TOPICAL	14.9 %w/w		Exact identifier — unii candidate 32 equally ranked IID candidates
ETHYLCELLULOSES	ETHYLCELLULOSE	7Z8S9VYZ4B	CAPSULE, EXTENDED RELEASE / ORAL		153 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
SACCHARIN SODIUM	SACCHARIN SODIUM	SB8ZUX40TY	TABLET / BUCCAL	0.4 mg		Exact identifier — unii+route 8 equally ranked IID candidates
CASTOR OIL	CASTOR OIL	D5340Y2I9G	TABLET / ORAL		17 mg	Exact identifier — unii candidate 32 equally ranked IID candidates
SACCHARIN SODIUM	SACCHARIN SODIUM	SB8ZUX40TY	FILM, SOLUBLE / BUCCAL		2 mg	Exact identifier — unii+route 8 equally ranked IID candidates
SUCRALOSE	SUCRALOSE	96K6UQ3ZD4	GUM, CHEWING / BUCCAL		70 mg	Exact identifier — unii+route 2 equally ranked IID candidates
SACCHARIN SODIUM	SACCHARIN SODIUM	SB8ZUX40TY	LIQUID / ORAL		3 mg	Exact identifier — unii+dosage form 8 equally ranked IID candidates
CASTOR OIL	CASTOR OIL	D5340Y2I9G	TABLET, COATED / ORAL	0.9 mg		Exact identifier — unii candidate 32 equally ranked IID candidates
CETYLPYRIDINIUM CHLORIDE	CETYLPYRIDINIUM CHLORIDE	D9OM4SK49P	CAPSULE, EXTENDED RELEASE / ORAL	0.02 mg		Exact identifier — unii candidate 10 equally ranked IID candidates
CASTOR OIL	CASTOR OIL	D5340Y2I9G	SOLUTION / TOPICAL	1.38 %w/w		Exact identifier — unii candidate 32 equally ranked IID candidates
ETHYLCELLULOSES	ETHYLCELLULOSE	7Z8S9VYZ4B	SUSPENSION, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii candidate 28 equally ranked IID candidates
CASTOR OIL	CASTOR OIL	D5340Y2I9G	INJECTION / INTRAMUSCULAR		885 mg	Exact identifier — unii candidate 32 equally ranked IID candidates
CETYLPYRIDINIUM CHLORIDE	CETYLPYRIDINIUM CHLORIDE	D9OM4SK49P	CAPSULE / ORAL		2 mg	Exact identifier — unii candidate 10 equally ranked IID candidates
CASTOR OIL	CASTOR OIL	D5340Y2I9G	INJECTION / INTRAMUSCULAR		885 mg	Exact identifier — unii candidate 32 equally ranked IID candidates
CASTOR OIL	CASTOR OIL	D5340Y2I9G	TABLET, DELAYED RELEASE / ORAL	0.01 mg		Exact identifier — unii candidate 32 equally ranked IID candidates
ETHYLCELLULOSES	ETHYLCELLULOSE	7Z8S9VYZ4B	POWDER / ORAL		2090 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
CASTOR OIL	CASTOR OIL	D5340Y2I9G	INJECTION, SOLUTION / INTRAMUSCULAR		525 mg	Exact identifier — unii candidate 32 equally ranked IID candidates
PROPYLENE GLYCOL	PROPYLENE GLYCOL	6DC9Q167V3	LIQUID / ORAL		29008 mg	Exact identifier — unii+dosage form 8 equally ranked IID candidates
SACCHARIN SODIUM	SACCHARIN SODIUM	SB8ZUX40TY	TABLET / BUCCAL	0.4 mg		Exact identifier — unii+route 8 equally ranked IID candidates
CASTOR OIL	CASTOR OIL	D5340Y2I9G	TABLET, FILM COATED / ORAL	15.29 mg		Exact identifier — unii candidate 32 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Kank-A Mouth Pain	BENZOCAINE	Blistex Inc.	eebc03ba-f849-4e70-a653-834f383b6aa4	2024-12-17	Warnings	Exact identifier ndc (package): 10157-9477-1 ndc (product): 10157-9477 ndc11 (package): 10157947701 spl id: 55568382-5b9f-4bc1-9532-38fb810532d3 spl set id: eebc03ba-f849-4e70-a653-834f383b6aa4

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.